Leipzig Tourismus und Marketing GmbH
6
Event Highlights Leipzig 2025
Ein Dokument
mehr
Ergebnis der Suchanfrage nach Baum
Newsrooms
baum reiter & collegen ...
HELLWEG Die Profi-Baumärkte GmbH & Co. KG
Baumann Unternehmensberatung
BAUMAX Maschinentechnik GmbH
BAUMDICK GmbH
Baumpflege Kasper GmbH
Alexander Baumer
Bananensprayer Thomas Baumgärtel
BK Baumeister & Kollegen
Bremer Baumdienst GmbH
Bremer Baumwollbörse
BRR Baumeister Rosing Rechtsanwälte
Bund deutscher Baumschulen (BdB) e.V.
Domäne Baumgartner
Gebr. Otto Baumwollfeinzwirnerei GmbH + Co. KG
Hornbach Baumarkt AG
Tobias Baumann
toom Baumarkt GmbH
GKK Ingenieurgesellschaft für Hochbau mbH
Initiative "Mein Erbe tut Gutes. Das ...
Kienbaum Consultants International GmbH
Lampmann, Haberkamm & Rosenbaum Rechtsanwälte
Museum am Rothenbaum
Poppelbaum Geigenmüller Rechtsanwälte
Tannenbaum-Blog
Verband Natürlicher Weihnachtsbaum e.V.
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
16 Treffer
Bluetooth® Stack Launches Next-gen Audio Streaming / New Low Energy Audio functionality enables more audio use cases and improved audio quality
Berlin/Utah (ots) - OpenSynergy announces the release of its Bluetooth® stack, Blue SDK v7, implementing entirely new Bluetooth profiles that enable advanced audio streaming over Bluetooth Low Energy. A new codec, called LC3, makes it possible to stream audio over Bluetooth Low Energy (LE), providing improved audio ...
mehrBreuninger presents the autumn/winter highlights for 2021 /Virtual season opening with "Shop the Look"
mehrVirtual shopping tour in the Kunstmuseum Stuttgart / Breuninger presents new digital format “Shop the Look”
mehrNew breast cancer study results published in The Lancet compare targeted radiotherapy during surgery with ZEISS INTRABEAM to traditional post-surgical radiotherapy treatment
Jena (ots) - 5-year results of international TARGIT-A clinical trial support targeted intraoperative radiotherapy (TARGIT) delivered with the ZEISS INTRABEAM as non-inferior to external beam radiotherapy (EBRT) for selected early stage breast cancer patients. Results of the TARGIT-A clinical trial published in The ...
mehreuro adhoc: Marseille-Kliniken AG / other / - Another substantial sale-and-lease-back transaction closed - Sales of 3 care and 3 rehabilitation facilities with a total real estate value of EUR 95.5 million - Rehabilitation segment increases inner reserve
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 29.06.2007 Berlin, June 29, 2007. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) successfully closed a third substantial sale-and-lease-back transaction with real estate ...
mehr
euro adhoc: Marseille-Kliniken AG / quarterly or semiannual financial statement / - Turnover increased to EUR168.4 m after three quarters - Above-average growth in adjusted result (DVFA/SG), increasing to EUR9.2 m - Continued expansion in revenue and re
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 9-month report 08.05.2007 Berlin, 8th May 2007. During the first three quarters of the 2006/2007 fiscal year, Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) further enhanced ...
mehreuro adhoc: Marseille-Kliniken AG / quarterly or semiannual financial statement / - Turnover increase to 52.8 million Euro in the first quarter of 2006/2007 - Companys DVFA/SG adjusted result increases above-average by 0.4 million Euro to 3.6 million Eu
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 08.11.2006 Berlin, 8th November 2006. The Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) continues improving its results in an above-average way. In the first quarter of the ...
mehreuro adhoc: Marseille-Kliniken AG / Dividend Announcements/Distribution / - Dividend increased thanks to positive earnings advance to EUR 0.45 - Majority shareholder family waives disbursement of its dividend
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 27.10.2006 Berlin, 27. October 2006. Marseille-Kliniken AG, (Prime Standard, ISIN DE 0007783003, MKA) will continue its shareholder-friendly dividend distribution policy this year thanks to the ...
mehreuro adhoc: Marseille-Kliniken AG / Financial Figures/Balance Sheet / - Turnover extended by 4.4% to 210.4 million Euro in financial year 2005/2006 - Company annual surplus increases by 3.4 million Euro to 9.7 million Euro - Capital ratio rises clearly
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 20.10.2006 Berlin, 20th October 2006. The Marseille-Kliniken AG, (Prime Standard, ISIN DE 0007783003, MKA) is continuing to grow and is recording above-average results. In the financial year of ...
mehreuro adhoc: Marseille-Kliniken AG / other / - Increase in total revenue to 156.9 Mio. EUR after three quarters - Increase in result (DVFA/SG) above average to 6.7 Mio. Euro - Equity ratio increases to 20.3%
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 09.05.2006 Berlin, 9th May 2006. The first three quarters of the trading year 2005/2006 have brought an increase in revenue of 3.1% for the Marseille-Kliniken AG (Prime Standard, ISIN DE ...
mehreuro adhoc: Marseille-Kliniken AG / quarterly or semiannual financial statement / - Above average increase in operating profit to EUR 5.8 mill. pursuant to DVFA - Turnover increases to EUR 104.9 mill. - Turnaround in Rehabilitation segment confirmed
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 08.02.2006 Berlin, 8th February 2006: The Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) has been able to increase its turnover in the first half of the fiscal year 2005/06 by ...
mehr
euro adhoc: Marseille-Kliniken AG / Financing, Stock Offerings (IPO) / - Another substantial sale-and-leaseback business is concluded - CIT Group purchases 10 portfolio properties in the care and rehabilitation sector for over EUR117m - Significant imp
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 06.12.2005 Berlin, 6th December 2005. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) was able to successfully conclude after the GE deal a second substantial sale-and-leaseback ...
mehreuro adhoc: Marseille-Kliniken AG / Quarterly or Semiannual Financial Statements / - Sales increased to EUR 152.1 million after three quarters - More and more positive signs from the Rehabilitation division - Full-year earnings expected to improve compar
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 09.05.2005 In the first three quarters of the fiscal year 2004/05, the Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) was able to further increase sales by 1.2% to EUR 152.1 ...
mehreuro adhoc: Marseille-Kliniken AG / other / · Successful closing in the sale-and-lease-back-business · GE Commercial Finance buys 12 properties from the care segment · Clear equity ratio improvement
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. The Marseille-Kliniken AG (prime standard, ISIN DE 0007783003, MKA) has successfully finalized a substantial sale-and-lease-back business with GE Commercial Finance. The Marseille-Kliniken AG ...
mehreuro adhoc: Marseille-Kliniken AG / Annual Reports / 5% increase in sales during the fiscal year 2003/2004 to 200.1 million Fundings for the Rehabilitation division depress total result to DVFA (IAS) to 7.5 million (previous year: 8.5 million) 1.
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) increased sales in the fiscal year 2003/04 by 5% to 200,1 million (previous year: 191.1 million). The earnings to DVFA/SG ...
mehr
1